Alzheimer's disease

Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease

Retrieved on: 
Monday, February 26, 2024

These relationships further the company’s goal to build the global infrastructure necessary for AD testing by expanding clinical access to Quanterix’s leading blood biomarker assays.

Key Points: 
  • These relationships further the company’s goal to build the global infrastructure necessary for AD testing by expanding clinical access to Quanterix’s leading blood biomarker assays.
  • This reach will provide greater access to patients for high-accuracy, non-invasive AD testing.
  • Traditional AD diagnosis has relied on combination of symptom presentation, brain imaging, and the detection of CSF biomarkers for AD.
  • “In our pursuit to build the global testing infrastructure for Alzheimer’s disease, Quanterix is pleased to work with several health systems whose combined networks treat millions of patients,” said Masoud Toloue, CEO of Quanterix.

Global IV Catheters Market Insights Report 2023-2029: Peripheral Inserted Central Catheters (PICCs) Leading the Charge - ResearchAndMarkets.com

Retrieved on: 
Friday, February 23, 2024

The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach a value of $6.64 billion by 2029, growing at a CAGR of 5.04%

Key Points: 
  • The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach a value of $6.64 billion by 2029, growing at a CAGR of 5.04%
    The global IV catheters market report contains exclusive data on 33 vendors.
  • BD, B Braun, Terumo, Teleflex, ICU Medical, and Nipro Medical are some leading players currently dominating the global IV catheters market.
  • The continuous growth in individuals with chronic conditions and the rapidly expanding elderly population are the primary factors fueling the global demand for peripheral IV catheters.
  • The peripheral inserted central catheters (PICCs) product segment accounted for the highest market share of over 45% of the global CIVCs market.

The Village at Willow Crossings Resident Care Associate Receives National Recognition for Inspired Caregiving & Service

Retrieved on: 
Thursday, March 7, 2024

MANSFIELD, Mass., March 7, 2024 /PRNewswire-PRWeb/ -- The Village at Willow Crossings, a Benchmark senior assisted living and Mind & Memory Care community, today announced that resident care associate, Carol Gordon of Mansfield, has been recognized for her significant contributions to her residents and senior living as a whole. Gordon is one of only four people nationally to be selected for the 2024 McKnight's Women of Distinction Spirit award, a joint program of McKnight's Long-Term Care News, McKnight's Senior Living and McKnight's Home Care.

Key Points: 
  • Since I was young, taking care of older people, and helping to heal those with Alzheimer's, dementia and other disorders has been my life's work."
  • -Carol Gordon, resident care associate, The Village at Willow Crossings
    Now in its sixth year, the award program honors women who have significantly impacted the senior living, skilled nursing or home care fields.
  • The Village at Willow Crossings is the only assisted living community in the greater Mansfield area to have earned U.S. News & World Report Best Senior Living designation.
  • Last year, the assisted living with memory care community earned both Best Assisted Living and Best Memory Care excellence awards.

Does Iron Accumulate in Brain After Concussions?

Retrieved on: 
Thursday, March 7, 2024

The study involved 60 people who had post-traumatic headache due to mild traumatic brain injury, or concussion.

Key Points: 
  • The study involved 60 people who had post-traumatic headache due to mild traumatic brain injury, or concussion.
  • The people with mild traumatic brain injuries were matched with 60 people who had not had concussions or post-traumatic headache.
  • All the participants had brain scans to look at iron levels in various areas of the brain, using an indirect measure for iron burden.
  • "Previous studies have shown that iron accumulation can affect how areas of the brain interact with each other," Nikolova said.

Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care

Retrieved on: 
Thursday, March 7, 2024

INDIANAPOLIS, March 7, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today launched the next phase of its Get Better corporate branding campaign with a new focus on obesity. Earlier this year, Lilly launched Get Better to reinforce its commitment to discovering and making medicines that give people a chance at better health.

Key Points: 
  • INDIANAPOLIS, March 7, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today launched the next phase of its Get Better corporate branding campaign with a new focus on obesity.
  • Earlier this year, Lilly launched Get Better to reinforce its commitment to discovering and making medicines that give people a chance at better health.
  • As a continuation of the larger campaign, Lilly will air two films - Shame and Big Night .
  • Shame, unveiled during Obesity Care Week, is designed to increase the dialogue about obesity as a serious disease and reinforce that there is no place for shame in the conversation around it.

BioArctic's partner Eisai presents updated sales simulation for Leqembi® at its annual press conference

Retrieved on: 
Thursday, March 7, 2024

STOCKHOLM, March 7, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq: BIOA B) (Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for Leqembi, the world's first fully approved disease-modifying treatment for Alzheimer's disease.

Key Points: 
  • STOCKHOLM, March 7, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq: BIOA B) (Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for Leqembi, the world's first fully approved disease-modifying treatment for Alzheimer's disease.
  • According to Eisai's simulation, Leqembi sales will reach JPY 290 billion for their financial year (FY) 2026, which ends in March 2027 and JPY 1.6 trillion in FY2032.
  • This information is information that BioArctic AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation.
  • The information was released for public disclosure, through the agency of the contact persons below, on March 7, 2023, at 06:30 a.m. CET.

BioArctic's partner Eisai presents updated sales simulation for Leqembi® at its annual press conference

Retrieved on: 
Thursday, March 7, 2024

STOCKHOLM, March 7, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq: BIOA B) (Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for Leqembi, the world's first fully approved disease-modifying treatment for Alzheimer's disease.

Key Points: 
  • STOCKHOLM, March 7, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq: BIOA B) (Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for Leqembi, the world's first fully approved disease-modifying treatment for Alzheimer's disease.
  • According to Eisai's simulation, Leqembi sales will reach JPY 290 billion for their financial year (FY) 2026, which ends in March 2027 and JPY 1.6 trillion in FY2032.
  • This information is information that BioArctic AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation.
  • The information was released for public disclosure, through the agency of the contact persons below, on March 7, 2023, at 06:30 a.m. CET.

People with Essential Tremor May Have Increased Risk of Dementia

Retrieved on: 
Wednesday, March 6, 2024

Essential tremor is the most common tremor disorder, more common than Parkinson's disease.

Key Points: 
  • Essential tremor is the most common tremor disorder, more common than Parkinson's disease.
  • "Not only do tremors affect a person's ability to complete daily tasks such writing and eating, our study suggests that people with essential tremor also have an increased risk of developing dementia."
  • The study involved 222 people with essential tremor who had an average age of 79 at the start of the study.
  • "While the majority of people with essential tremor will not develop dementia, our findings provide the basis for physicians to educate people with essential tremor and their families about the heightened risk, and any potential life changes likely to accompany this diagnosis," Louis said.

EISAI INVESTS IN C2N TO SUPPORT SIMPLIFYING THE DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE TO BETTER SERVE PATIENTS

Retrieved on: 
Tuesday, March 5, 2024

By investing in C2N, Eisai seeks to support efforts to advance blood-based Aβ diagnostics that are accurate and affordable, providing new options for confirming the presence of Aβ.

Key Points: 
  • By investing in C2N, Eisai seeks to support efforts to advance blood-based Aβ diagnostics that are accurate and affordable, providing new options for confirming the presence of Aβ.
  • "The field of highly accurate blood-based diagnostics is rapidly advancing and expanding," said Keisuke Naito, Global Alzheimer's Disease Officer, Senior Vice President, Eisai.
  • "Given the expense and capacity limitations of PET and CSF tests, Eisai is working to support the dementia ecosystem's growth.
  • The availability of more affordable and minimally invasive diagnostic tools helps support broad access for the management of Alzheimer's disease."

AARP Bulletin's March Issue: Unlocking the Secrets of a Stress-Free Tax Season, Grocery Store Deceits That Cost You, and the Hot Job Market (for Dogs)

Retrieved on: 
Tuesday, March 5, 2024

WASHINGTON, March 5, 2024 /PRNewswire/ -- The March 2024 issue of AARP Bulletin will offer readers an array of helpful tips – from navigating tax season as an older American to advice on how to avoid common and timely scams. Plus, our cover story notes good news in the world of Alzheimer's treatment.

Key Points: 
  • The March AARP Bulletin offers tips for tax filers of all ages.
  • The following are highlights from this month's Bulletin:
    Truth is, the likelihood of getting your taxes audited by the Internal Revenue Service these days are near record lows.
  • But a handful of mistakes in how you fill out – or submit!
  • AARP Bulletin details the mistakes or oversights that are most important to avoid.